Advertisement

Index by author

October 2009; Volume 37,Issue 10

A

  1. Amidon, Gordon L.

    1. Multiple Efflux Pumps Are Involved in the Transepithelial Transport of Colchicine: Combined Effect of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 Leads to Decreased Intestinal Absorption Throughout the Entire Small Intestine
      Arik Dahan, Hairat Sabit and Gordon L. Amidon
      Drug Metabolism and Disposition October 2009, 37 (10) 2028-2036; DOI: https://doi.org/10.1124/dmd.109.028282

  2. Amin, Shantu

    1. Functional Characterization of Low-Prevalence Missense Polymorphisms in the UDP-Glucuronosyltransferase 1A9 Gene
      Kristine C. Olson, Ryan W. Dellinger, Qing Zhong, Dongxiao Sun, Shantu Amin, Thomas E. Spratt and Philip Lazarus
      Drug Metabolism and Disposition October 2009, 37 (10) 1999-2007; DOI: https://doi.org/10.1124/dmd.108.024596

  3. Augustine, Lisa M.

    1. Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
      Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. Ferguson and Nathan J. Cherrington
      Drug Metabolism and Disposition October 2009, 37 (10) 2087-2094; DOI: https://doi.org/10.1124/dmd.109.027466

B

  1. Bartlett, M. G.

    1. Presystemic Elimination of Trichloroethylene in Rats Following Environmentally Relevant Oral Exposures
      Y. Liu, M. G. Bartlett, C. A. White, S. Muralidhara and J. V. Bruckner
      Drug Metabolism and Disposition October 2009, 37 (10) 1994-1998; DOI: https://doi.org/10.1124/dmd.109.028100

  2. Boekens, Hilmar

    1. Absorption, Disposition, Metabolic Fate, and Elimination of the Dopamine Agonist Rotigotine in Man: Administration by Intravenous Infusion or Transdermal Delivery
      Willi Cawello, Marina Braun and Hilmar Boekens
      Drug Metabolism and Disposition October 2009, 37 (10) 2055-2060; DOI: https://doi.org/10.1124/dmd.109.027383

  3. Bohanec Grabar, Petra

    1. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
      Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
      Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482

  4. Bondesson, Ulf

    1. Identification of Finasteride Metabolites in Human Bile and Urine by High-Performance Liquid Chromatography/Tandem Mass Spectrometry
      Anna Lundahl, Hans Lennernäs, Lars Knutson, Ulf Bondesson and Mikael Hedeland
      Drug Metabolism and Disposition October 2009, 37 (10) 2008-2017; DOI: https://doi.org/10.1124/dmd.109.027870

  5. Braun, Marina

    1. Absorption, Disposition, Metabolic Fate, and Elimination of the Dopamine Agonist Rotigotine in Man: Administration by Intravenous Infusion or Transdermal Delivery
      Willi Cawello, Marina Braun and Hilmar Boekens
      Drug Metabolism and Disposition October 2009, 37 (10) 2055-2060; DOI: https://doi.org/10.1124/dmd.109.027383

  6. Bruckner, J. V.

    1. Presystemic Elimination of Trichloroethylene in Rats Following Environmentally Relevant Oral Exposures
      Y. Liu, M. G. Bartlett, C. A. White, S. Muralidhara and J. V. Bruckner
      Drug Metabolism and Disposition October 2009, 37 (10) 1994-1998; DOI: https://doi.org/10.1124/dmd.109.028100

C

  1. Cawello, Willi

    1. Absorption, Disposition, Metabolic Fate, and Elimination of the Dopamine Agonist Rotigotine in Man: Administration by Intravenous Infusion or Transdermal Delivery
      Willi Cawello, Marina Braun and Hilmar Boekens
      Drug Metabolism and Disposition October 2009, 37 (10) 2055-2060; DOI: https://doi.org/10.1124/dmd.109.027383

  2. Cherrington, Nathan J.

    1. Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
      Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. Ferguson and Nathan J. Cherrington
      Drug Metabolism and Disposition October 2009, 37 (10) 2087-2094; DOI: https://doi.org/10.1124/dmd.109.027466

  3. Cook, Ian T.

    1. 24-Hydroxycholesterol Sulfation by Human Cytosolic Sulfotransferases: Formation of Monosulfates and Disulfates, Molecular Modeling, Sulfatase Sensitivity, and Inhibition of Liver X Receptor Activation
      Ian T. Cook, Zofia Duniec-Dmuchowski, Thomas A. Kocarek, Melissa Runge-Morris and Charles N. Falany
      Drug Metabolism and Disposition October 2009, 37 (10) 2069-2078; DOI: https://doi.org/10.1124/dmd.108.025759

D

  1. D'Agostino, Jaime

    1. The Pneumotoxin 3-Methylindole Is a Substrate and a Mechanism-Based Inactivator of CYP2A13, a Human Cytochrome P450 Enzyme Preferentially Expressed in the Respiratory Tract
      Jaime D'Agostino, Xiaoliang Zhuo, Mohammad Shadid, Daniel G. Morgan, Xiuling Zhang, W. Griffith Humphreys, Yue-Zhong Shu, Garold S. Yost and Xinxin Ding
      Drug Metabolism and Disposition October 2009, 37 (10) 2018-2027; DOI: https://doi.org/10.1124/dmd.109.027300

  2. Dahan, Arik

    1. Multiple Efflux Pumps Are Involved in the Transepithelial Transport of Colchicine: Combined Effect of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 Leads to Decreased Intestinal Absorption Throughout the Entire Small Intestine
      Arik Dahan, Hairat Sabit and Gordon L. Amidon
      Drug Metabolism and Disposition October 2009, 37 (10) 2028-2036; DOI: https://doi.org/10.1124/dmd.109.028282

  3. Davaalkham, Jagdagsuren

    1. Allele and Genotype Frequencies of Cytochrome P450 2B6 Gene in a Mongolian Population
      Jagdagsuren Davaalkham, Tsunefusa Hayashida, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Dulmaa Nyamkhuu and Shinichi Oka
      Drug Metabolism and Disposition October 2009, 37 (10) 1991-1993; DOI: https://doi.org/10.1124/dmd.109.027755

  4. Degawa, Masakuni

    1. 4-Hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl-Mediated Decrease in Serum Thyroxine Level in Mice Occurs through Increase in Accumulation of Thyroxine in the Liver
      Yoshihisa Kato, Koichi Haraguchi, Makiko Kubota, Yoshiki Seto, Shin-ichi Ikushiro, Toshiyuki Sakaki, Nobuyuki Koga, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition October 2009, 37 (10) 2095-2102; DOI: https://doi.org/10.1124/dmd.109.028621

  5. Dellinger, Ryan W.

    1. Functional Characterization of Low-Prevalence Missense Polymorphisms in the UDP-Glucuronosyltransferase 1A9 Gene
      Kristine C. Olson, Ryan W. Dellinger, Qing Zhong, Dongxiao Sun, Shantu Amin, Thomas E. Spratt and Philip Lazarus
      Drug Metabolism and Disposition October 2009, 37 (10) 1999-2007; DOI: https://doi.org/10.1124/dmd.108.024596

  6. Ding, Xinxin

    1. The Pneumotoxin 3-Methylindole Is a Substrate and a Mechanism-Based Inactivator of CYP2A13, a Human Cytochrome P450 Enzyme Preferentially Expressed in the Respiratory Tract
      Jaime D'Agostino, Xiaoliang Zhuo, Mohammad Shadid, Daniel G. Morgan, Xiuling Zhang, W. Griffith Humphreys, Yue-Zhong Shu, Garold S. Yost and Xinxin Ding
      Drug Metabolism and Disposition October 2009, 37 (10) 2018-2027; DOI: https://doi.org/10.1124/dmd.109.027300

  7. Dolžan, Vita

    1. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
      Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
      Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482

  8. Duniec-Dmuchowski, Zofia

    1. 24-Hydroxycholesterol Sulfation by Human Cytosolic Sulfotransferases: Formation of Monosulfates and Disulfates, Molecular Modeling, Sulfatase Sensitivity, and Inhibition of Liver X Receptor Activation
      Ian T. Cook, Zofia Duniec-Dmuchowski, Thomas A. Kocarek, Melissa Runge-Morris and Charles N. Falany
      Drug Metabolism and Disposition October 2009, 37 (10) 2069-2078; DOI: https://doi.org/10.1124/dmd.108.025759

F

  1. Falany, Charles N.

    1. 24-Hydroxycholesterol Sulfation by Human Cytosolic Sulfotransferases: Formation of Monosulfates and Disulfates, Molecular Modeling, Sulfatase Sensitivity, and Inhibition of Liver X Receptor Activation
      Ian T. Cook, Zofia Duniec-Dmuchowski, Thomas A. Kocarek, Melissa Runge-Morris and Charles N. Falany
      Drug Metabolism and Disposition October 2009, 37 (10) 2069-2078; DOI: https://doi.org/10.1124/dmd.108.025759

  2. Felim, Anne

    1. Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
      Melanie Mueller, Jie Yuan, Anne Felim, Anne Neudörffer, Frank T. Peters, Hans H. Maurer, Una D. McCann, Martine Largeron and George A. Ricaurte
      Drug Metabolism and Disposition October 2009, 37 (10) 2079-2086; DOI: https://doi.org/10.1124/dmd.109.028340

  3. Ferguson, Stephen S.

    1. Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
      Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. Ferguson and Nathan J. Cherrington
      Drug Metabolism and Disposition October 2009, 37 (10) 2087-2094; DOI: https://doi.org/10.1124/dmd.109.027466

  4. Fischer, H. David

    1. Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 3
      Andrew J. Lickteig, Rochelle Riley, Roger J. Melton, Beverly A. Reitz, H. David Fischer and Jeffrey C. Stevens
      Drug Metabolism and Disposition October 2009, 37 (10) 1987-1990; DOI: https://doi.org/10.1124/dmd.109.027714

  5. Fisher, Craig D.

    1. Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
      Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. Ferguson and Nathan J. Cherrington
      Drug Metabolism and Disposition October 2009, 37 (10) 2087-2094; DOI: https://doi.org/10.1124/dmd.109.027466

G

  1. Gao, Wenqing

    1. MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting
      Yu-Zhuo Pan, Wenqing Gao and Ai-Ming Yu
      Drug Metabolism and Disposition October 2009, 37 (10) 2112-2117; DOI: https://doi.org/10.1124/dmd.109.027680

  2. Gatanaga, Hiroyuki

    1. Allele and Genotype Frequencies of Cytochrome P450 2B6 Gene in a Mongolian Population
      Jagdagsuren Davaalkham, Tsunefusa Hayashida, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Dulmaa Nyamkhuu and Shinichi Oka
      Drug Metabolism and Disposition October 2009, 37 (10) 1991-1993; DOI: https://doi.org/10.1124/dmd.109.027755

  3. Gibson, Remi

    1. In Vitro Inhibition and Induction of Human Liver Cytochrome P450 Enzymes by Milnacipran
      Brandy L. Paris, Brian W. Ogilvie, Julie A. Scheinkoenig, Florence Ndikum-Moffor, Remi Gibson and Andrew Parkinson
      Drug Metabolism and Disposition October 2009, 37 (10) 2045-2054; DOI: https://doi.org/10.1124/dmd.109.028274

  4. Grabnar, Iztok

    1. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
      Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
      Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482

H

  1. Haraguchi, Koichi

    1. 4-Hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl-Mediated Decrease in Serum Thyroxine Level in Mice Occurs through Increase in Accumulation of Thyroxine in the Liver
      Yoshihisa Kato, Koichi Haraguchi, Makiko Kubota, Yoshiki Seto, Shin-ichi Ikushiro, Toshiyuki Sakaki, Nobuyuki Koga, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition October 2009, 37 (10) 2095-2102; DOI: https://doi.org/10.1124/dmd.109.028621

  2. Hayashida, Tsunefusa

    1. Allele and Genotype Frequencies of Cytochrome P450 2B6 Gene in a Mongolian Population
      Jagdagsuren Davaalkham, Tsunefusa Hayashida, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Dulmaa Nyamkhuu and Shinichi Oka
      Drug Metabolism and Disposition October 2009, 37 (10) 1991-1993; DOI: https://doi.org/10.1124/dmd.109.027755

  3. Hedeland, Mikael

    1. Identification of Finasteride Metabolites in Human Bile and Urine by High-Performance Liquid Chromatography/Tandem Mass Spectrometry
      Anna Lundahl, Hans Lennernäs, Lars Knutson, Ulf Bondesson and Mikael Hedeland
      Drug Metabolism and Disposition October 2009, 37 (10) 2008-2017; DOI: https://doi.org/10.1124/dmd.109.027870

  4. Hirouchi, Masakazu

    1. Construction of Triple-Transfected Cells [Organic Anion-Transporting Polypeptide (OATP) 1B1/Multidrug Resistance-Associated Protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for Analysis of the Sinusoidal Function of MRP3 and MRP4
      Masakazu Hirouchi, Hiroyuki Kusuhara, Reiko Onuki, Brian W. Ogilvie, Andrew Parkinson and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2009, 37 (10) 2103-2111; DOI: https://doi.org/10.1124/dmd.109.027193

  5. Humphreys, W. Griffith

    1. The Pneumotoxin 3-Methylindole Is a Substrate and a Mechanism-Based Inactivator of CYP2A13, a Human Cytochrome P450 Enzyme Preferentially Expressed in the Respiratory Tract
      Jaime D'Agostino, Xiaoliang Zhuo, Mohammad Shadid, Daniel G. Morgan, Xiuling Zhang, W. Griffith Humphreys, Yue-Zhong Shu, Garold S. Yost and Xinxin Ding
      Drug Metabolism and Disposition October 2009, 37 (10) 2018-2027; DOI: https://doi.org/10.1124/dmd.109.027300

I

  1. Ikushiro, Shin-ichi

    1. 4-Hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl-Mediated Decrease in Serum Thyroxine Level in Mice Occurs through Increase in Accumulation of Thyroxine in the Liver
      Yoshihisa Kato, Koichi Haraguchi, Makiko Kubota, Yoshiki Seto, Shin-ichi Ikushiro, Toshiyuki Sakaki, Nobuyuki Koga, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition October 2009, 37 (10) 2095-2102; DOI: https://doi.org/10.1124/dmd.109.028621

J

  1. Jackson, Jonathan P.

    1. Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
      Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. Ferguson and Nathan J. Cherrington
      Drug Metabolism and Disposition October 2009, 37 (10) 2087-2094; DOI: https://doi.org/10.1124/dmd.109.027466

K

  1. Kato, Yoshihisa

    1. 4-Hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl-Mediated Decrease in Serum Thyroxine Level in Mice Occurs through Increase in Accumulation of Thyroxine in the Liver
      Yoshihisa Kato, Koichi Haraguchi, Makiko Kubota, Yoshiki Seto, Shin-ichi Ikushiro, Toshiyuki Sakaki, Nobuyuki Koga, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition October 2009, 37 (10) 2095-2102; DOI: https://doi.org/10.1124/dmd.109.028621

  2. Knutson, Lars

    1. Identification of Finasteride Metabolites in Human Bile and Urine by High-Performance Liquid Chromatography/Tandem Mass Spectrometry
      Anna Lundahl, Hans Lennernäs, Lars Knutson, Ulf Bondesson and Mikael Hedeland
      Drug Metabolism and Disposition October 2009, 37 (10) 2008-2017; DOI: https://doi.org/10.1124/dmd.109.027870

  3. Kocarek, Thomas A.

    1. 24-Hydroxycholesterol Sulfation by Human Cytosolic Sulfotransferases: Formation of Monosulfates and Disulfates, Molecular Modeling, Sulfatase Sensitivity, and Inhibition of Liver X Receptor Activation
      Ian T. Cook, Zofia Duniec-Dmuchowski, Thomas A. Kocarek, Melissa Runge-Morris and Charles N. Falany
      Drug Metabolism and Disposition October 2009, 37 (10) 2069-2078; DOI: https://doi.org/10.1124/dmd.108.025759

  4. Koga, Nobuyuki

    1. 4-Hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl-Mediated Decrease in Serum Thyroxine Level in Mice Occurs through Increase in Accumulation of Thyroxine in the Liver
      Yoshihisa Kato, Koichi Haraguchi, Makiko Kubota, Yoshiki Seto, Shin-ichi Ikushiro, Toshiyuki Sakaki, Nobuyuki Koga, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition October 2009, 37 (10) 2095-2102; DOI: https://doi.org/10.1124/dmd.109.028621

  5. Kubota, Makiko

    1. 4-Hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl-Mediated Decrease in Serum Thyroxine Level in Mice Occurs through Increase in Accumulation of Thyroxine in the Liver
      Yoshihisa Kato, Koichi Haraguchi, Makiko Kubota, Yoshiki Seto, Shin-ichi Ikushiro, Toshiyuki Sakaki, Nobuyuki Koga, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition October 2009, 37 (10) 2095-2102; DOI: https://doi.org/10.1124/dmd.109.028621

  6. Kusuhara, Hiroyuki

    1. Construction of Triple-Transfected Cells [Organic Anion-Transporting Polypeptide (OATP) 1B1/Multidrug Resistance-Associated Protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for Analysis of the Sinusoidal Function of MRP3 and MRP4
      Masakazu Hirouchi, Hiroyuki Kusuhara, Reiko Onuki, Brian W. Ogilvie, Andrew Parkinson and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2009, 37 (10) 2103-2111; DOI: https://doi.org/10.1124/dmd.109.027193

L

  1. Largeron, Martine

    1. Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
      Melanie Mueller, Jie Yuan, Anne Felim, Anne Neudörffer, Frank T. Peters, Hans H. Maurer, Una D. McCann, Martine Largeron and George A. Ricaurte
      Drug Metabolism and Disposition October 2009, 37 (10) 2079-2086; DOI: https://doi.org/10.1124/dmd.109.028340

  2. Lazarus, Philip

    1. Functional Characterization of Low-Prevalence Missense Polymorphisms in the UDP-Glucuronosyltransferase 1A9 Gene
      Kristine C. Olson, Ryan W. Dellinger, Qing Zhong, Dongxiao Sun, Shantu Amin, Thomas E. Spratt and Philip Lazarus
      Drug Metabolism and Disposition October 2009, 37 (10) 1999-2007; DOI: https://doi.org/10.1124/dmd.108.024596

  3. Lennernäs, Hans

    1. Identification of Finasteride Metabolites in Human Bile and Urine by High-Performance Liquid Chromatography/Tandem Mass Spectrometry
      Anna Lundahl, Hans Lennernäs, Lars Knutson, Ulf Bondesson and Mikael Hedeland
      Drug Metabolism and Disposition October 2009, 37 (10) 2008-2017; DOI: https://doi.org/10.1124/dmd.109.027870

  4. Lickteig, Andrew J.

    1. Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 3
      Andrew J. Lickteig, Rochelle Riley, Roger J. Melton, Beverly A. Reitz, H. David Fischer and Jeffrey C. Stevens
      Drug Metabolism and Disposition October 2009, 37 (10) 1987-1990; DOI: https://doi.org/10.1124/dmd.109.027714
    2. Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
      Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. Ferguson and Nathan J. Cherrington
      Drug Metabolism and Disposition October 2009, 37 (10) 2087-2094; DOI: https://doi.org/10.1124/dmd.109.027466

  5. Liu, Y.

    1. Presystemic Elimination of Trichloroethylene in Rats Following Environmentally Relevant Oral Exposures
      Y. Liu, M. G. Bartlett, C. A. White, S. Muralidhara and J. V. Bruckner
      Drug Metabolism and Disposition October 2009, 37 (10) 1994-1998; DOI: https://doi.org/10.1124/dmd.109.028100

  6. Logar, Dušan

    1. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
      Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
      Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482

  7. Lundahl, Anna

    1. Identification of Finasteride Metabolites in Human Bile and Urine by High-Performance Liquid Chromatography/Tandem Mass Spectrometry
      Anna Lundahl, Hans Lennernäs, Lars Knutson, Ulf Bondesson and Mikael Hedeland
      Drug Metabolism and Disposition October 2009, 37 (10) 2008-2017; DOI: https://doi.org/10.1124/dmd.109.027870

M

  1. Makishima, Makoto

    1. Modulation of Bile Acid Metabolism by 1α-Hydroxyvitamin D3 Administration in Mice
      Shigeru Nishida, Jun Ozeki and Makoto Makishima
      Drug Metabolism and Disposition October 2009, 37 (10) 2037-2044; DOI: https://doi.org/10.1124/dmd.109.027334

  2. Maurer, Hans H.

    1. Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
      Melanie Mueller, Jie Yuan, Anne Felim, Anne Neudörffer, Frank T. Peters, Hans H. Maurer, Una D. McCann, Martine Largeron and George A. Ricaurte
      Drug Metabolism and Disposition October 2009, 37 (10) 2079-2086; DOI: https://doi.org/10.1124/dmd.109.028340

  3. McCann, Una D.

    1. Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
      Melanie Mueller, Jie Yuan, Anne Felim, Anne Neudörffer, Frank T. Peters, Hans H. Maurer, Una D. McCann, Martine Largeron and George A. Ricaurte
      Drug Metabolism and Disposition October 2009, 37 (10) 2079-2086; DOI: https://doi.org/10.1124/dmd.109.028340

  4. Melton, Roger J.

    1. Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 3
      Andrew J. Lickteig, Rochelle Riley, Roger J. Melton, Beverly A. Reitz, H. David Fischer and Jeffrey C. Stevens
      Drug Metabolism and Disposition October 2009, 37 (10) 1987-1990; DOI: https://doi.org/10.1124/dmd.109.027714

  5. Morgan, Daniel G.

    1. The Pneumotoxin 3-Methylindole Is a Substrate and a Mechanism-Based Inactivator of CYP2A13, a Human Cytochrome P450 Enzyme Preferentially Expressed in the Respiratory Tract
      Jaime D'Agostino, Xiaoliang Zhuo, Mohammad Shadid, Daniel G. Morgan, Xiuling Zhang, W. Griffith Humphreys, Yue-Zhong Shu, Garold S. Yost and Xinxin Ding
      Drug Metabolism and Disposition October 2009, 37 (10) 2018-2027; DOI: https://doi.org/10.1124/dmd.109.027300

  6. Mrhar, Aleš

    1. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
      Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
      Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482

  7. Mueller, Melanie

    1. Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
      Melanie Mueller, Jie Yuan, Anne Felim, Anne Neudörffer, Frank T. Peters, Hans H. Maurer, Una D. McCann, Martine Largeron and George A. Ricaurte
      Drug Metabolism and Disposition October 2009, 37 (10) 2079-2086; DOI: https://doi.org/10.1124/dmd.109.028340

  8. Muralidhara, S.

    1. Presystemic Elimination of Trichloroethylene in Rats Following Environmentally Relevant Oral Exposures
      Y. Liu, M. G. Bartlett, C. A. White, S. Muralidhara and J. V. Bruckner
      Drug Metabolism and Disposition October 2009, 37 (10) 1994-1998; DOI: https://doi.org/10.1124/dmd.109.028100

N

  1. Ndikum-Moffor, Florence

    1. In Vitro Inhibition and Induction of Human Liver Cytochrome P450 Enzymes by Milnacipran
      Brandy L. Paris, Brian W. Ogilvie, Julie A. Scheinkoenig, Florence Ndikum-Moffor, Remi Gibson and Andrew Parkinson
      Drug Metabolism and Disposition October 2009, 37 (10) 2045-2054; DOI: https://doi.org/10.1124/dmd.109.028274

  2. Neudörffer, Anne

    1. Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
      Melanie Mueller, Jie Yuan, Anne Felim, Anne Neudörffer, Frank T. Peters, Hans H. Maurer, Una D. McCann, Martine Largeron and George A. Ricaurte
      Drug Metabolism and Disposition October 2009, 37 (10) 2079-2086; DOI: https://doi.org/10.1124/dmd.109.028340

  3. Nishida, Shigeru

    1. Modulation of Bile Acid Metabolism by 1α-Hydroxyvitamin D3 Administration in Mice
      Shigeru Nishida, Jun Ozeki and Makoto Makishima
      Drug Metabolism and Disposition October 2009, 37 (10) 2037-2044; DOI: https://doi.org/10.1124/dmd.109.027334

  4. Nyamkhuu, Dulmaa

    1. Allele and Genotype Frequencies of Cytochrome P450 2B6 Gene in a Mongolian Population
      Jagdagsuren Davaalkham, Tsunefusa Hayashida, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Dulmaa Nyamkhuu and Shinichi Oka
      Drug Metabolism and Disposition October 2009, 37 (10) 1991-1993; DOI: https://doi.org/10.1124/dmd.109.027755

O

  1. Ogilvie, Brian W.

    1. In Vitro Inhibition and Induction of Human Liver Cytochrome P450 Enzymes by Milnacipran
      Brandy L. Paris, Brian W. Ogilvie, Julie A. Scheinkoenig, Florence Ndikum-Moffor, Remi Gibson and Andrew Parkinson
      Drug Metabolism and Disposition October 2009, 37 (10) 2045-2054; DOI: https://doi.org/10.1124/dmd.109.028274
    2. Construction of Triple-Transfected Cells [Organic Anion-Transporting Polypeptide (OATP) 1B1/Multidrug Resistance-Associated Protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for Analysis of the Sinusoidal Function of MRP3 and MRP4
      Masakazu Hirouchi, Hiroyuki Kusuhara, Reiko Onuki, Brian W. Ogilvie, Andrew Parkinson and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2009, 37 (10) 2103-2111; DOI: https://doi.org/10.1124/dmd.109.027193

  2. Oka, Shinichi

    1. Allele and Genotype Frequencies of Cytochrome P450 2B6 Gene in a Mongolian Population
      Jagdagsuren Davaalkham, Tsunefusa Hayashida, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Dulmaa Nyamkhuu and Shinichi Oka
      Drug Metabolism and Disposition October 2009, 37 (10) 1991-1993; DOI: https://doi.org/10.1124/dmd.109.027755

  3. Olson, Kristine C.

    1. Functional Characterization of Low-Prevalence Missense Polymorphisms in the UDP-Glucuronosyltransferase 1A9 Gene
      Kristine C. Olson, Ryan W. Dellinger, Qing Zhong, Dongxiao Sun, Shantu Amin, Thomas E. Spratt and Philip Lazarus
      Drug Metabolism and Disposition October 2009, 37 (10) 1999-2007; DOI: https://doi.org/10.1124/dmd.108.024596

  4. Onuki, Reiko

    1. Construction of Triple-Transfected Cells [Organic Anion-Transporting Polypeptide (OATP) 1B1/Multidrug Resistance-Associated Protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for Analysis of the Sinusoidal Function of MRP3 and MRP4
      Masakazu Hirouchi, Hiroyuki Kusuhara, Reiko Onuki, Brian W. Ogilvie, Andrew Parkinson and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2009, 37 (10) 2103-2111; DOI: https://doi.org/10.1124/dmd.109.027193

  5. Ozeki, Jun

    1. Modulation of Bile Acid Metabolism by 1α-Hydroxyvitamin D3 Administration in Mice
      Shigeru Nishida, Jun Ozeki and Makoto Makishima
      Drug Metabolism and Disposition October 2009, 37 (10) 2037-2044; DOI: https://doi.org/10.1124/dmd.109.027334

P

  1. Pan, Yu-Zhuo

    1. MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting
      Yu-Zhuo Pan, Wenqing Gao and Ai-Ming Yu
      Drug Metabolism and Disposition October 2009, 37 (10) 2112-2117; DOI: https://doi.org/10.1124/dmd.109.027680

  2. Paris, Brandy L.

    1. In Vitro Inhibition and Induction of Human Liver Cytochrome P450 Enzymes by Milnacipran
      Brandy L. Paris, Brian W. Ogilvie, Julie A. Scheinkoenig, Florence Ndikum-Moffor, Remi Gibson and Andrew Parkinson
      Drug Metabolism and Disposition October 2009, 37 (10) 2045-2054; DOI: https://doi.org/10.1124/dmd.109.028274

  3. Parkinson, Andrew

    1. In Vitro Inhibition and Induction of Human Liver Cytochrome P450 Enzymes by Milnacipran
      Brandy L. Paris, Brian W. Ogilvie, Julie A. Scheinkoenig, Florence Ndikum-Moffor, Remi Gibson and Andrew Parkinson
      Drug Metabolism and Disposition October 2009, 37 (10) 2045-2054; DOI: https://doi.org/10.1124/dmd.109.028274
    2. Construction of Triple-Transfected Cells [Organic Anion-Transporting Polypeptide (OATP) 1B1/Multidrug Resistance-Associated Protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for Analysis of the Sinusoidal Function of MRP3 and MRP4
      Masakazu Hirouchi, Hiroyuki Kusuhara, Reiko Onuki, Brian W. Ogilvie, Andrew Parkinson and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2009, 37 (10) 2103-2111; DOI: https://doi.org/10.1124/dmd.109.027193

  4. Peterlin Mašič, Lucija

    1. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
      Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
      Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482

  5. Peters, Frank T.

    1. Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
      Melanie Mueller, Jie Yuan, Anne Felim, Anne Neudörffer, Frank T. Peters, Hans H. Maurer, Una D. McCann, Martine Largeron and George A. Ricaurte
      Drug Metabolism and Disposition October 2009, 37 (10) 2079-2086; DOI: https://doi.org/10.1124/dmd.109.028340

R

  1. Ranger-Moore, James

    1. Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
      Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. Ferguson and Nathan J. Cherrington
      Drug Metabolism and Disposition October 2009, 37 (10) 2087-2094; DOI: https://doi.org/10.1124/dmd.109.027466

  2. Reitz, Beverly A.

    1. Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 3
      Andrew J. Lickteig, Rochelle Riley, Roger J. Melton, Beverly A. Reitz, H. David Fischer and Jeffrey C. Stevens
      Drug Metabolism and Disposition October 2009, 37 (10) 1987-1990; DOI: https://doi.org/10.1124/dmd.109.027714

  3. Ricaurte, George A.

    1. Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
      Melanie Mueller, Jie Yuan, Anne Felim, Anne Neudörffer, Frank T. Peters, Hans H. Maurer, Una D. McCann, Martine Largeron and George A. Ricaurte
      Drug Metabolism and Disposition October 2009, 37 (10) 2079-2086; DOI: https://doi.org/10.1124/dmd.109.028340

  4. Riley, Rochelle

    1. Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 3
      Andrew J. Lickteig, Rochelle Riley, Roger J. Melton, Beverly A. Reitz, H. David Fischer and Jeffrey C. Stevens
      Drug Metabolism and Disposition October 2009, 37 (10) 1987-1990; DOI: https://doi.org/10.1124/dmd.109.027714

  5. Rozman, Blaž

    1. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
      Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
      Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482

  6. Runge-Morris, Melissa

    1. 24-Hydroxycholesterol Sulfation by Human Cytosolic Sulfotransferases: Formation of Monosulfates and Disulfates, Molecular Modeling, Sulfatase Sensitivity, and Inhibition of Liver X Receptor Activation
      Ian T. Cook, Zofia Duniec-Dmuchowski, Thomas A. Kocarek, Melissa Runge-Morris and Charles N. Falany
      Drug Metabolism and Disposition October 2009, 37 (10) 2069-2078; DOI: https://doi.org/10.1124/dmd.108.025759

S

  1. Sabit, Hairat

    1. Multiple Efflux Pumps Are Involved in the Transepithelial Transport of Colchicine: Combined Effect of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 Leads to Decreased Intestinal Absorption Throughout the Entire Small Intestine
      Arik Dahan, Hairat Sabit and Gordon L. Amidon
      Drug Metabolism and Disposition October 2009, 37 (10) 2028-2036; DOI: https://doi.org/10.1124/dmd.109.028282

  2. Sakaki, Toshiyuki

    1. 4-Hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl-Mediated Decrease in Serum Thyroxine Level in Mice Occurs through Increase in Accumulation of Thyroxine in the Liver
      Yoshihisa Kato, Koichi Haraguchi, Makiko Kubota, Yoshiki Seto, Shin-ichi Ikushiro, Toshiyuki Sakaki, Nobuyuki Koga, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition October 2009, 37 (10) 2095-2102; DOI: https://doi.org/10.1124/dmd.109.028621

  3. Scheinkoenig, Julie A.

    1. In Vitro Inhibition and Induction of Human Liver Cytochrome P450 Enzymes by Milnacipran
      Brandy L. Paris, Brian W. Ogilvie, Julie A. Scheinkoenig, Florence Ndikum-Moffor, Remi Gibson and Andrew Parkinson
      Drug Metabolism and Disposition October 2009, 37 (10) 2045-2054; DOI: https://doi.org/10.1124/dmd.109.028274

  4. Seto, Yoshiki

    1. 4-Hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl-Mediated Decrease in Serum Thyroxine Level in Mice Occurs through Increase in Accumulation of Thyroxine in the Liver
      Yoshihisa Kato, Koichi Haraguchi, Makiko Kubota, Yoshiki Seto, Shin-ichi Ikushiro, Toshiyuki Sakaki, Nobuyuki Koga, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition October 2009, 37 (10) 2095-2102; DOI: https://doi.org/10.1124/dmd.109.028621

  5. Shadid, Mohammad

    1. The Pneumotoxin 3-Methylindole Is a Substrate and a Mechanism-Based Inactivator of CYP2A13, a Human Cytochrome P450 Enzyme Preferentially Expressed in the Respiratory Tract
      Jaime D'Agostino, Xiaoliang Zhuo, Mohammad Shadid, Daniel G. Morgan, Xiuling Zhang, W. Griffith Humphreys, Yue-Zhong Shu, Garold S. Yost and Xinxin Ding
      Drug Metabolism and Disposition October 2009, 37 (10) 2018-2027; DOI: https://doi.org/10.1124/dmd.109.027300

  6. Shu, Yue-Zhong

    1. The Pneumotoxin 3-Methylindole Is a Substrate and a Mechanism-Based Inactivator of CYP2A13, a Human Cytochrome P450 Enzyme Preferentially Expressed in the Respiratory Tract
      Jaime D'Agostino, Xiaoliang Zhuo, Mohammad Shadid, Daniel G. Morgan, Xiuling Zhang, W. Griffith Humphreys, Yue-Zhong Shu, Garold S. Yost and Xinxin Ding
      Drug Metabolism and Disposition October 2009, 37 (10) 2018-2027; DOI: https://doi.org/10.1124/dmd.109.027300

  7. Spratt, Thomas E.

    1. Functional Characterization of Low-Prevalence Missense Polymorphisms in the UDP-Glucuronosyltransferase 1A9 Gene
      Kristine C. Olson, Ryan W. Dellinger, Qing Zhong, Dongxiao Sun, Shantu Amin, Thomas E. Spratt and Philip Lazarus
      Drug Metabolism and Disposition October 2009, 37 (10) 1999-2007; DOI: https://doi.org/10.1124/dmd.108.024596

  8. Stevens, Jeffrey C.

    1. Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 3
      Andrew J. Lickteig, Rochelle Riley, Roger J. Melton, Beverly A. Reitz, H. David Fischer and Jeffrey C. Stevens
      Drug Metabolism and Disposition October 2009, 37 (10) 1987-1990; DOI: https://doi.org/10.1124/dmd.109.027714

  9. Sugiyama, Yuichi

    1. Construction of Triple-Transfected Cells [Organic Anion-Transporting Polypeptide (OATP) 1B1/Multidrug Resistance-Associated Protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for Analysis of the Sinusoidal Function of MRP3 and MRP4
      Masakazu Hirouchi, Hiroyuki Kusuhara, Reiko Onuki, Brian W. Ogilvie, Andrew Parkinson and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2009, 37 (10) 2103-2111; DOI: https://doi.org/10.1124/dmd.109.027193

  10. Sun, Dongxiao

    1. Functional Characterization of Low-Prevalence Missense Polymorphisms in the UDP-Glucuronosyltransferase 1A9 Gene
      Kristine C. Olson, Ryan W. Dellinger, Qing Zhong, Dongxiao Sun, Shantu Amin, Thomas E. Spratt and Philip Lazarus
      Drug Metabolism and Disposition October 2009, 37 (10) 1999-2007; DOI: https://doi.org/10.1124/dmd.108.024596

  11. Šuput, Daša

    1. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
      Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
      Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482

T

  1. Tomšič, Matija

    1. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
      Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
      Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482

  2. Trdan, Tina

    1. Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
      Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
      Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482

  3. Tsuchiya, Kiyoto

    1. Allele and Genotype Frequencies of Cytochrome P450 2B6 Gene in a Mongolian Population
      Jagdagsuren Davaalkham, Tsunefusa Hayashida, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Dulmaa Nyamkhuu and Shinichi Oka
      Drug Metabolism and Disposition October 2009, 37 (10) 1991-1993; DOI: https://doi.org/10.1124/dmd.109.027755

W

  1. White, C. A.

    1. Presystemic Elimination of Trichloroethylene in Rats Following Environmentally Relevant Oral Exposures
      Y. Liu, M. G. Bartlett, C. A. White, S. Muralidhara and J. V. Bruckner
      Drug Metabolism and Disposition October 2009, 37 (10) 1994-1998; DOI: https://doi.org/10.1124/dmd.109.028100

Y

  1. Yamada, Shizuo

    1. 4-Hydroxy-2,2′,3,4′,5,5′,6-heptachlorobiphenyl-Mediated Decrease in Serum Thyroxine Level in Mice Occurs through Increase in Accumulation of Thyroxine in the Liver
      Yoshihisa Kato, Koichi Haraguchi, Makiko Kubota, Yoshiki Seto, Shin-ichi Ikushiro, Toshiyuki Sakaki, Nobuyuki Koga, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition October 2009, 37 (10) 2095-2102; DOI: https://doi.org/10.1124/dmd.109.028621

  2. Yost, Garold S.

    1. The Pneumotoxin 3-Methylindole Is a Substrate and a Mechanism-Based Inactivator of CYP2A13, a Human Cytochrome P450 Enzyme Preferentially Expressed in the Respiratory Tract
      Jaime D'Agostino, Xiaoliang Zhuo, Mohammad Shadid, Daniel G. Morgan, Xiuling Zhang, W. Griffith Humphreys, Yue-Zhong Shu, Garold S. Yost and Xinxin Ding
      Drug Metabolism and Disposition October 2009, 37 (10) 2018-2027; DOI: https://doi.org/10.1124/dmd.109.027300

  3. Yu, Ai-Ming

    1. MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting
      Yu-Zhuo Pan, Wenqing Gao and Ai-Ming Yu
      Drug Metabolism and Disposition October 2009, 37 (10) 2112-2117; DOI: https://doi.org/10.1124/dmd.109.027680

  4. Yuan, Jie

    1. Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
      Melanie Mueller, Jie Yuan, Anne Felim, Anne Neudörffer, Frank T. Peters, Hans H. Maurer, Una D. McCann, Martine Largeron and George A. Ricaurte
      Drug Metabolism and Disposition October 2009, 37 (10) 2079-2086; DOI: https://doi.org/10.1124/dmd.109.028340

Z

  1. Zhang, Xiuling

    1. The Pneumotoxin 3-Methylindole Is a Substrate and a Mechanism-Based Inactivator of CYP2A13, a Human Cytochrome P450 Enzyme Preferentially Expressed in the Respiratory Tract
      Jaime D'Agostino, Xiaoliang Zhuo, Mohammad Shadid, Daniel G. Morgan, Xiuling Zhang, W. Griffith Humphreys, Yue-Zhong Shu, Garold S. Yost and Xinxin Ding
      Drug Metabolism and Disposition October 2009, 37 (10) 2018-2027; DOI: https://doi.org/10.1124/dmd.109.027300

  2. Zhong, Qing

    1. Functional Characterization of Low-Prevalence Missense Polymorphisms in the UDP-Glucuronosyltransferase 1A9 Gene
      Kristine C. Olson, Ryan W. Dellinger, Qing Zhong, Dongxiao Sun, Shantu Amin, Thomas E. Spratt and Philip Lazarus
      Drug Metabolism and Disposition October 2009, 37 (10) 1999-2007; DOI: https://doi.org/10.1124/dmd.108.024596

  3. Zhuo, Xiaoliang

    1. The Pneumotoxin 3-Methylindole Is a Substrate and a Mechanism-Based Inactivator of CYP2A13, a Human Cytochrome P450 Enzyme Preferentially Expressed in the Respiratory Tract
      Jaime D'Agostino, Xiaoliang Zhuo, Mohammad Shadid, Daniel G. Morgan, Xiuling Zhang, W. Griffith Humphreys, Yue-Zhong Shu, Garold S. Yost and Xinxin Ding
      Drug Metabolism and Disposition October 2009, 37 (10) 2018-2027; DOI: https://doi.org/10.1124/dmd.109.027300
Back to top

In this issue

Advertisement